4-hydroxy-2',4',6'-trichlorobiphenyl has been researched along with tamoxifen in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loch-Caruso, R; Tsai, ML; Webb, RC | 1 |
| Gaido, K; Pallaroni, L; Safe, S; Stoner, M; Yoon, K | 1 |
2 other study(ies) available for 4-hydroxy-2',4',6'-trichlorobiphenyl and tamoxifen
| Article | Year |
|---|---|
Increase of oxytocin-induced oscillatory contractions by 4-hydroxy-2',4',6'-trichlorobiphenyl is estrogen receptor mediated.
Topics: Animals; Estradiol; Estrogen Antagonists; Female; Oxytocin; Polychlorinated Biphenyls; Potassium Chloride; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Tamoxifen; Uterine Contraction | 1997 |
Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements.
Topics: Benzhydryl Compounds; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Estrogens, Non-Steroidal; Fulvestrant; Humans; Phenols; Polychlorinated Biphenyls; Polymorphism, Genetic; Receptors, Estrogen; Response Elements; Tamoxifen; Transfection; Tumor Cells, Cultured | 2001 |